Skip to content
Research Article Open access CC BY 4.0

Real Time Cell Analysis of Model Target Cell Lines Exposed to Purified Lipoprotein (a)

Alice Santonastaso, Claudia Scotti

Journal of Advances in Medicine and Medical Research · pp. 1–12 · Published 8 Jun 2016

10.9734/BJMMR/2016/26869

Abstract

Lipoprotein (a) [Lp(a)] is a novel independent cardiovascular risk factor and it includes, beyond apoB100, apolipoprotein (a), whose molecular weight is dependent on the number of genetically encoded kringle IV type 2 repeats and inversely related with Lp(a) plasma concentration. Risk thresholds for molecular weights have been proposed, but there is not a full consensus and the role of the different isoforms in pathogenesis has not yet been clarified. The aim of the present work is to explore the biological effect of low and high molecular weight Lp(a) isoforms on cultured cells. Real-time impedance analysis has been performed on model cell lines of atherogenesis and Lp(a) metabolism (THP-1, HUVEC, HASMC and HepG2) using affinity purified Lp(a) with 22 (low number) and 31 (high number) kringle IV type 2 repeats, respectively. Normalized Cell Index data show that all the cell lines tested are modified by Lp(a), though with a variable intensity. Low and high molecular weight Lp(a) isoforms at similar concentrations can exert opposite modifications on the impedance kinetics of different cell lines. These data suggest that purified Lp(a) can modify the behaviour of adherent cell lines, an effect which can be detected as impedance variation and which is influenced by its specific isoform.

Lipoprotein (a) kringle IV type 2 isoforms HepG2 THP-1 HUVEC HASMC

References (33)

  1. 1 Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction [DOI]
  2. 2 Macrophage Phenotype and Function in Different Stages of Atherosclerosis [DOI]
  3. 3 Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress [DOI]
  4. 4 Mechanisms and consequences of macrophage apoptosis in atherosclerosis [DOI]
  5. 5 Handbook of Lipoprotein Testing
  6. 6 Use of a Reference Material Proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to Evaluate Analytical Methods for the Determination of Plasma Lipoprotein(a) [DOI]
  7. 7 Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac‐1 integrin [DOI]
  8. 8 Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. [DOI]
  9. 9 Proliferation of Human Smooth Muscle Cells Promoted by Lipoprotein(a) [DOI]
  10. 10 The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. [DOI]
  11. 11 Scavenger receptor-BI is a receptor for lipoprotein(a) [DOI]
  12. 12 Lipoprotein [a] is cleared from the plasma primarily by the liver in a process mediated by apolipoprotein [a] [DOI]
  13. 13 Identification of Megalin/gp330 as a Receptor for Lipoprotein(a) In Vitro [DOI]
  14. 14 Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: Role of oxidative stress [DOI]
  15. 15 Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study [DOI]
  16. 16 Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries [DOI]
  17. 17 Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism [DOI]
  18. 18 Interaction of a recombinant form of apolipoprotein[a] with human fibroblasts and with the human hepatoma cell line HepG2 [DOI]
  19. 19 Estrogen attenuates vascular remodeling in Lp(a) transgenic mice [DOI]
  20. 20 Lipoprotein (a) upregulates ABCA1 in liver cells via scavenger receptor-B1 through its oxidized phospholipids [DOI]
  21. 21 Comparative Analyses of the Lysine Binding Site Properties of Apolipoprotein(a) Kringle IV Types 7 and 10 [DOI]
  22. 22 Lipoprotein(a) Isoforms Display Differences in Affinity for Plasminogen-Like Binding to Human Mononuclear Cells [DOI]
  23. 23 Mitogenic Activity of Oxidized Lipoprotein (a) on Human Vascular Smooth Muscle Cells [DOI]
  24. 24 Lipoprotein(a) stimulates the proliferation of cultured human arterial smooth muscle cells through two pathways [DOI]
  25. 25 LDL-mediated interaction of Lp[a] with HepG2 cells: a novel fluorescence microscopy approach [DOI]
  26. 26 Proliferation of human smooth muscle cells promoted by lipoprotein(a) [DOI]
  27. 27 Effects of lipoprotein(a) and low density lipoprotein on growth of mitogen-stimulated human umbilical vein endothelial cells [DOI]
  28. 28 Characterization of the basis of lipoprotein [a] lysine-binding heterogeneity [DOI]
  29. 29 Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis [DOI]
  30. 30 Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension [DOI]
  31. 31 Stimulatory effects of lipoprotein(a) and low-density lipoprotein on human umbilical vein endothelial cell migration and proliferation are partially mediated by fibroblast growth factor-2 [DOI]
  32. 32 Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries [DOI]
  33. 33 Handbook of lipoprotein testing [DOI]

Cited by 1

Article metrics

Real usage data collected on this platform.

85

Page views

0

PDF downloads

39

Outbound clicks

1

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.